Clinically, pSS is characterized by overexpression of oxidative stress-related biomarkers and proinflammatory cytokines, such as tumor necrosis factor-alpha (TNF-α), interleukin-6 (IL-6), IL-12, IL-18, and gamma-interferon (12). This evidence concerns the gene IL6 and peeling skin syndrome.